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Abstract: Plant-based systems continue to play an essential role in healthcare, and their use by
different cultures has been extensively documented. Asphodelus L. (Asphodelaceae) is a genus of
18 species and of a total of 27 species, sub-species and varieties, distributed along the Mediterranean
basin, and has been traditionally used for treating several diseases particularly associated with
inflammatory and infectious skin disorders. The present study aimed to provide a general review
of the available literature on ethnomedical, phytochemical, and biological data related to the genus
Asphodelus as a potential source of new compounds with biological activity. Considering phytochemical
studies, 1,8-dihydroxyanthracene derivatives, flavonoids, phenolic acids and triterpenoids were the
main classes of compounds identified in roots, leaf and seeds which were correlated with their
biological activities as anti-microbial, anti-fungal, anti-parasitic, cytotoxic, anti-inflammatory or
antioxidant agents.
Keywords: anthracene derivatives; antimicrobial; Asphodelus; ethnomedicine; skin diseases
1. Introduction
The genus Asphodelus Linnaeus belongs to family Asphodelaceae Jussieu and is native to temperate
Europe, the Mediterranean, Africa, the Middle East, and the Indian Subcontinent, and now naturalized
in other places (New Zealand, Australia, Mexico, southwestern United States, etc.) [1]. It reaches its
maximum diversity in the West of the Mediterranean, particularly in the Iberian Peninsula and in
North-West Africa [2].
The family consists of three subfamilies: Asphodeloideae Burnett (including 13 genera),
Hemerocallidoideae Lindley (including 19 genera) and Xanthorrhoeoideae M.W. Chase (with only one
genus). This botanical family, now called Asphodelaceae, has had a complex history; its circumscription
and placement in an order have varied widely. In the Cronquist system of 1981, members of the
Asphodelaceae were placed in the order Liliales Perleb [3,4]. Cronquist had difficulty classifying the
less obviously delineated lilioid monocots; consequently, he placed taxa from both the modern orders
Asparagales Link and Liliales into a single family, Liliaceae Jussieu [5]. The decision to group three
formerly separate families, Asphodelaceae, Hemerocallidaceae and Xanthorrhoeaceae, into a single family
first occurred in 2003 as an option in the II Angiosperm Phylogeny Group (APG) classification for the
orders and families of flowering plants. The name used for the broader family was then Xanthorrhoeaceae
Dumortier [6], and the earlier references to this family were related only to subfamily Xanthorrhoeoideae.
These changes were a consequence of improvements in molecular and morphological analysis and also
a reflection of the increased emphasis on placing families within an appropriate order [5,7,8]. Later in
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2009, the APG III classification dropped the option of keeping the three families separate, using only
the expanded family, still under the name Xanthorrhoeaceae [7]. Anticipating a decision to conserve the
name Asphodelaceae over Xanthorrhoeaceae, the APG IV classification of 2016 used Asphodelaceae as the
name for the expanded family [9].
According to the World Checklist of Selected Plant Families (WCSP), there are 32 accepted names
with more than 150 homo- and heterotypic synonyms for all species, subspecies and varieties of the
genus Asphodelus L. namely, Asphodelus acaulis Desfontaines, Asphodelus aestivus Brotero, Asphodelus
albus Miller (subsp. albus; subsp. carpetanus Z. Díaz & Valdés; subsp. delphinensis (Grenier & Godron)
Z. Díaz & Valdés; subsp. occidentalis (Jordan) Z. Díaz & Valdés), Asphodelus ayardii Jahandiez & Maire,
Asphodelus bakeri Breistroffer, Asphodelus bento-rainhae P. Silva (subsp. bento-rainhae; subsp. salmanticus
Z. Díaz & Valdés), Asphodelus cerasiferus J. Gay, Asphodelus fistulosus Linnaeus (subsp. fistulosus;
subsp. madeirensis Simon), Asphodelus gracilis Braun-Blanquet & Maire, Asphodelus lusitanicus Coutinho
(var. lusitanicus; var. ovoideus (Merino) Z. Díaz & Valdés), Asphodelus macrocarpus Parlatore (subsp.
macrocarpus; subsp. rubescens Z. Díaz & Valdés; var. arrondeaui (J. Lloyd) Z. Díaz & Valdés), Asphodelus
ramosus Linnaeus (subsp. distalis Z. Díaz & Valdés; subsp. Ramosus); Asphodelus refractus Boissier,
Asphodelus roseus Humbert & Maire, Asphodelus serotinus Wolley-Dod, Asphodelus tenuifolius Cavanilles,
and Asphodelus viscidulus Boissier [1]. However, on the Missouri Botanical Garden database (Tropicos),
more two accepted names (Asphodelus cerasifer Gay and Asphodelus microcarpus Salzmann & Viviani)
were recorded [10]. Considering all the above-mentioned data 18 species and of a total of 27 species,
sub-species and varieties must be considered for the Asphodelus genus.
Among all the species, A. aestivus and A. fistulosus are inscribed as “Least Concern” and A.
bento-rainhae as “Vulnerable” species on International Union for the Conservation of Nature (IUCN)
Red List of Threatened Species [11].
Botanical and systematic descriptions of this genus have been discussed by several taxonomists
in various flora publications. The plants are hardy herbaceous perennials with narrow tufted radical
leaves and an elongated stem bearing a spike of white or yellow flowers. Many have a small
rhizomatous crown and thick, fleshy roots [12].
Different ethnomedical uses were described to Asphodelus species. Different parts of the plant
including leaf, fruit, seed, flower, and root are used as traditional herbal medicines, alone or in mixtures
to treat various ailments. In Iberian Peninsula, the following general medicinal uses were described: by
rubbing with the cut tubers for the treatment of skin eczema, the ashes of the roots were used against
the alopecia, and the leaves and stems decoction was used for the treatment of paralysis and the juice
of fresh capsules for earache treatment [2]. Medicinal usage of the Asphodelus genus is also common in
North African, and West and South Asian countries. Beside its medicinal uses, in Iberian Peninsula the
alcohol obtained by fermentation of the tubers is extracted and used as fuel [2] and the local people of
Iran, Turkey and Egypt use the root tubers of A. aestivus and A. microcarpus to produce a strong glue
used by shoemakers and cobblers [2,13,14], and as yellow and brown dyes to dye the wool [2].
Root tubers are used as daily food, after being moistened and fried beforehand to eliminate the
astringent compounds, and also the young stem, the leaves and the roasted seeds [2,15].
This study aims to present a comprehensive and updated review of documented ethnomedicinal
and ethnopharmacological studies including chemical and biological data concerning Asphodelus genus.
2. Results and Discussion
Table 1 summarizes the ethnomedicinal data about the Asphodelus species including specific
information on the plant parts as well as the geographical region where the plant is used. In Table 2
the principal chemical studies and identified compounds of the genus are presented. Tables 3 and 4
summarize the principals of in vitro and in vivo biological activity assays on the total extracts and
isolated compounds.
Plants 2018, 7, 20 3 of 17
2.1. Ethnomedical Studies
Ethnomedicinal records showed that among the 18 species of the genus Asphodelus, only five species
namely A. aestivus, A. fistulosus, A. microcarpus, A. ramosus, and A. tenuifolius have been documented
for their traditional uses (Table 1). Most commonly, these species were used as anti-inflammatory
and anti-infective agents. In particular, A. aestivus, A. fistulosus and A. microcarpus were reported to be
used in dermatomucosal infections in various countries including Cyprus, Egypt, Libya, Palestine, and
Spain [16–20]. A. microcarpus, A. ramosus and A. tenuifolius were generally indicted as anti-inflammatory
agents specifically for the treatment of psoriasis, eczema, and rheumatism [21–28]. A. aestivus and
A. tenuifolius are also used for ulcer treatment in Turkey, India, and Pakistan [26–29]. A. ramosus and
A. tenuifolius have frequently been reported as diuretics among the inhabitants of Egypt, India, Pakistan,
and Turkey [24,25,27–31].
Table 1. Ethnomedicinal uses of the Asphodelus species.
Species Part Used Country Traditional Uses/Application References
A. aestivus
L, R Turkey Peptic ulcers [32]
R Turkey Haemorrhoids, burns, wounds and nephritis [33]
NI Cyprus, Spain Skin diseases [16]
A. fistulosus NI Egypt, Libya Fungal infections [17]
A. luteus * WP Palestine Dermatomucosal infections [18]
A. microcarpus
FR, L, R Egypt Ear-ache, withering and paralysis [13,14]
R Palestine Dermatomucosal infections [18]
R Egypt Ectodermal parasites, jaundice, microbialinfections and psoriasis [19–21]
NI Algeria Ear-ache, eczema, colds and rheumatism [22]
A. ramosus R North-Africa Inflammatory disorders [23]
NI Turkey Anti-tumoral, diuretic and emmenagogue [29]
A. tenuifolius
L India Diuretic, inflammatory disorders and ulcers [24]
L, SE Egypt Diuretic [30]
R, SE India
Antipyretic, diuretic, colds and hemorrhoids,
inflammatory disorders, rheumatic pain, ulcers
and wounds
[25,27]
SE Pakistan ulcers and inflammatory disorders [26]
WP India Diuretic, inflammatory disorders, bite of bees andwasps, ulcers [28,34]
NI Pakistan Diuretic [31]
SE: Seed; L: Leaf; WP: Whole plant; FR: Fruit; R: Root; NI: Not indicated, * Asphodelus luteus L.—synonym of
Asphodeline lutea was formerly included in the family Asphodelaceae.
2.2. Phytochemical Studies
Phytochemical studies as shown in Table 2, revealed the presence of different groups of compounds
namely anthraquinones (either in the free or in the glycoside form), phenolic acids, flavonoids, and
triterpenoids from A. acaulis, A. albus, A. aestivus, A. cerasiferus, A. fistulosus, A. microcarpus, A. ramosus,
and A. tenuifolius.
Roots were mainly reported to have anthraquinone derivatives such as chrysophanol and
aloe-emodin, triterpenoids, and naphthalene derivatives, while aerial parts mostly exhibited
the presence of flavonoids such as luteolin, isovitexin and isoorientin, phenolic acids, and few
anthraquinones. Fatty acids, namely myristic, palmitic, oleic, linoleic, and linolenic, were found
in seeds and roots. Only A. aestivus and A. microcarpus were studied for essential oil characterization of
flowers [22,35].
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Table 2. Identified compounds reported from Asphodelus genus.
Species Part Used Class Name of Compounds References
A. acaulis
L Flavonoids Luteolin; apigenin [36]
R Anthraquinones Chrysophanol; asphodelin; 10,7′-bichrysophanol [37]
A. aestivus
FL n-alkenes Hexadecanoic acid (35.6%), pentacosane (17.4%), tricosane (13.4%), heptacosane (8.4%), heneicosane (4.5%), phytol (4.5%),tetracosane (3%), hexacosane (2%), hexahydrofarnesyl acetone (1.7%), tetradecanoic acid (1.4%), docosane (1.3%), nonadecane (1%) [35]
L
Amino acids Adenosine; tryptophan; phenylalanine
[38]
Anthraquinones Aloe-emodin; aloe-emodin acetate; chyrosphanol 1-O-gentiobioside
Flavonoids Isovitexin; isoorientin; isoorientin 4
′-O-β glucopyranoside; 6′ ′-O-(malonyl)-isoorientin;
6′ ′-O-[(S)-3-hydroxy-3-methylglutaroyl]-isoorientin
Phenolic acid Chlorogenic acid
SE Fatty acids Butyric acid; nervoic acid [39]
A. albus
L
Anthraquinones Aloe-emodin; chrysophanol [36,40]
Flavonoid Luteolin [36]
R
Anthraquinones Chrysophanol; asphodelin; 10,7′-bichrysophanol [37]
Fatty acids Myristic (5.3%); palmitic (18.5%); stearic (2.1%); oleic (13.5%); linoleic (44.1%); linolenic (9.9%); arachidic (2.7%); behenic (1.2%);lignoceric (2.1%) acids [41]
Triterpenoids β-sitosterol; β-amyrin; campesterol; stigmasterol; fucosterol
A. albus var. delphinensis R Anthraquinones Asphodeline; microcorpine; aloe-emodine; chrysophanole [42]
A. cerasifer
L
Anthraquinones Aloe-emodin [36]
Flavonoids Isoorientin; luteolin; luteolin 7-glucoside [36,43]
R Anthraquinones Asphodeline; microcorpine; aloe-emodine; chrysophanole [41]
* A. delphinensis L Flavonoids Isoorientin; luteolin; luteolin 7-glucoside [43]
A. fistulosus
AP
Anthraquinones Asphodelin; asphodelin 10′-anthrone; aloesaponarin II; aloe-emodin; chrysophanol; desoxyerythrolaccin
[17]
Flavonoids Chrysoeriol; luteolin
L Anthraquinones Dianhydrorugulosin; aloe-emodin; chrysophanol; 1,8 hydroxy-dianthraquinone [44]
R Anthraquinones Chrysophanol; asphodelin; 10,7′-Bichrysophanol [37]
SE
Anthraquinones Dianhydrorugulosin; aloe-emodin; chrysophanol; 1,8 hydroxy-dianthraquinone [44]
Carbohydrates Sucrose; raffinose; stachyose [45]
Fatty acids Myristic (0.5%); palmitic (5.7%); stearic (3.6%); oleic (33.1%); linoleic (54.9%) [45,46]
Triterpenoids β-sitosterol; β-amyrin [45]
** A. luteus L Anthraquinones Aloe-emodin [36]
*** A. mauritii Sennen L
Anthraquinones Aloe-emodin; chrysophanol
[36]
Flavonoids Luteolin
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Table 2. Cont.
Species Part Used Class Name of Compounds References
A. microcarpus
FL
Terpenoids Germacrene D (78.3%); germacrene B (3.9%); a-elemene (3.8%); caryophyllene (3.3%) [22]
Flavonoids Luteolin; luteolin-6-C-glucoside; luteolin-O-hexoside; luteolin-7-O-glucoside; luteolin-O-acetylglucoside;luteolin-O-deoxyhesosylhexoside; methyl-luteolin, naringenin; apigenin [47]
Phenolic acids 3-O caffeoylquinic acid; 5-O caffeoylquinic acid
L
Anthraquinone Chrysophanol, 10 (chrysophanol-7-yl)-10-Hydroxychrysophanol-9-antrone, asphodoside C, Dianhydrorugulosin; aloe-emodin [44,48]
Flavonoids Luteolin-6-C-glucoside; luteolin-6-C-acetilglucoside; luteolin-C-glucoside; luteolin, isoorientin [43,49]
Phenolic acids 5-O caffeoylquinic acid; cichoric acid; cumaril exosa malic acid [49]
R
Anthraquinones
Dianhydrorugulosin; aloe-emodin; chrysophanol; asphodelin; microcarpin, 8 methoxychrysophanol; emodin;
10-(chrysophanol-7′-yl)-10-hydroxychrysophanol-9-anthrone; aloesaponol-III-8-methyl ether; ramosin; aestivin, asphodosides A-E,
chrysophanol dianthraquinone; 5,5′-bichrysophanol; chrysophanol-8-mono-β-D-glucoside;
Methyl-1,4,5-trihydroxy-7-methyl-9,10-dioxo-9,10-dihydroanthracene-2-carboxylate; 6 methoxychrysophanol
[21,44,50–54]
Arylcoumarins Asphodelin A 4′-O-β-D-glucoside; asphodelin A [19]
Carbohydrates Raffinose; sucrose; glucose; fructose [55]
Fatty acids Palmitic; stearic; oleic; linoleic; linolenic; arachidic; behenic; lignoceric; myristic acids [55,56]
Naphthalene
derivatives 2-acetyl-1,8-dimethoxy-3 methylnaphthalene; 1,6-dimethoxy-3-methyl-2-naphthoic acid [21]
Mucilage Composed of glucose; galactose; arabinose [55]
Triterpenoids β-sitosterol-β-D-glucoside, fucosterol [13,55]
SE
Anthraquinones Aloe-emodin; chrysophanol; chrysophanol-8-mono-β-D-glucoside [44]
Carbohydrates Sucrose; raffinose; stachyose; melibiose
[45]Fatty acids Myristic; palmitic; stearic; oleic; linoleic acids
Triterpenoids β-sitosterol; β-amyrin
A. ramosus
FL
Flavonoids Luteolin
[57]
Phenolic acids Caffeic acid; chlorogenic acid; p-hydroxy-benzoic acids
L Flavonoids Luteolin; 7-O-glucosyl luteolin; 7-O-glucosyl apigenin; isoorientin; isoswertiajaponin (7-methyl orientin); isocytisoside (4
′-methyl
vitexin) [29]
R Anthraquinone
Ramosin; (−)-10′-C-[β-D-xylopyranosyl]-; (−)-10′-C-[β-D-glucopyranosyl-(1-4)-β-D-glucopyranosyl]-1,1′,8,8,10,10′-hexa
hydroxy -3,3′-dimethyl-10,7′ bianthracene-9,9′-dione; 10′-deoxy-10-epi-ramosin;
10-(chrysophanol-7′-yl)-10-hydroxychrysophanol-9-anthrone;
7′-(Chrysophanol-4-yl)-chrysophanol-10′anthrone10′-C-α-rhamnopyranosyl; -C-β-xylopyranosyl; -C-β-antiaropyranosyl;
-C-α-arabinopyranosyl; -C-β-quinovoopyranosyl
[58–60]
WP
Flavonoids Naringin, quercetin, kaemferol
[61]
Phenolic acids Gallic acid, chlorogenic acid, vanilic acid, cafeic acid
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Table 2. Cont.
Species Part Used Class Name of Compounds References
A. tenuifolius
AP Flavonoids Luteolin; luteolin-7-O-β-D-glycopyranoside; apigenin, chrysoeriol [30]
R
Naphthalene
derivatives 1,8-dimethylnaphthalene; 2-acetyl-8-methoxy-3-methyl-1-naphthol; 2-acetyl-1,8-dimethoxy-3-methylnaphthalene [62]
Triterpenoids β-sitosterol; stigmasterol
SE
Ester 1-O-17methylstearylmyoinositol [63]
Fatty acids Myristic (3.96%); palmitic (13.84%); oleic (15.60%); linoleic (62.62%); linolenic (2.60%) [64,65]
WP
Amino acids Crystine; serine; glycine; proline; alanine, glycin; serine; alanine and valine in the form of protein
[66]
Carbohydrates D-glucose; lactose; D-glucuronic acid; D-arabinose; D-fructose, D-ribose
Chromone 2-hentriacontyl-5,7-dihydroxy-8-methyl-4H-1-benzopyran-4-one [31]
Triterpenoids Asphorodin; asphorin A; asphorin B; β-sitosterol; β-amyrin [26,28,31]
AP: Aerial Part; FL: Flower; FR: Fruit; L: Leaf; R: Root; SE: Seed; WP: Whole plant; NI: Not indicated; * The accepted name is Asphodelus albus subsp. delphinensis (Gren. & Godr.).
** Asphodelus luteus L.—synonym of Asphodeline lutea was formerly included in the family Asphodelaceae. *** The accepted name is Asphodelus macrocarpus subsp. rubescens.
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2.3. Reported Biological Activities
In vitro and in vivo biological studies concerning Asphodelus extracts are presented in Table 3 and
those reported from identified pure compounds are shown in Table 4. In some of the studies, no data
were obtained concerning the tested doses and/or inhibitory values.
The ethanol and aqueous extracts of A. aestivus leaf showed moderate anti-fungal activity against
Aspergillus niger [33], and whole plant ethanol extracts exhibited weak activity against Staphylococcus
aureus with minimum inhibitory concentration (MIC) = 42 mg/mL) and Klebsiella pneumoniae
(MIC = 60 mg/mL) [67]. Both leaf and root extracts showed strong antioxidant activity [15,68]. The root
extract also showed significant anti-inflammatory properties, specifically anti-ulcer activity which
is one of the documented uses in Turkish traditional medicine [32]. Root and leaf extracts showed
antitumoral activity against human cancer cells (lung and prostate) through DNA damage [68,69].
The aerial parts extracts of A. luteus showed strong anti-fungal activity against Trichophyton
violaceum (MIC = 18 µg/mL), Microsporum canis (MIC = 25 µg/mL), and Trichophyton mentagrophytes
(MIC = 30 µg/mL) supporting their traditional use in dermatomucosal infections [18] and weak
activity against methicillin-resistant Staphylococcus aureus (MRSA) isolates (MIC = 1.25–2.5 mg/mL) [70].
Moreover, the methanol root extracts showed moderate antioxidant activity against 2,2-diphenyl-1-
picrylhydrazyl free radicals (DPPH; IC50 = 0.54 mg/mL) [61].
The aerial parts and root extracts of A. microcarpus showed moderate antioxidant [47,61] and
moderate to weak cytotoxic activities [48,49,71]. The ethanol extracts of leaves demonstrated strong
antiviral activity against Ebola virus (EBOV) in the concentration of 0.1–0.3 µg/mL [49]. Although the
leaf seems to have stronger antimicrobial activity in comparison with roots, in general, both exhibit
weak or no antimicrobial/antifungal activity [20,48,49,70]; however, compounds isolated from root
tubers extracts showed potent activity such as asphodelin A against S. aureus (MIC = 16 µg/mL),
Escherichia coli (MIC = 4 µg/mL), Pseudomonas aeruginosa (MIC = 8 µg/mL), Candida albicans
(MIC = 64 µg/mL) [19] and Botrytis cinerea (MIC = 128 µg/mL) and asphodoside B against MRSA
(IC50 = 1.62 µg/mL) [51]. Other isolated compounds from root extracts showed different biological
activity; for instance, ramosin showed potent cytotoxic activity against leukemia cell lines [21], aestivin
showed potent antimalarial activity against chloroquine-sensitive and resistant strains of Plasmodium
falciparum with IC50 of 0.8–0.7 µg/mL [21] and 3,4-dihydroxy-methyl benzoate exhibited anti-parasitic
activity against Leishmania donovani promastigotes with IC50 of 33.2 µg/mL [54].
Root extracts of A. ramosus showed positive in vivo anti-inflammatory activity, confirming the
traditional uses of the plant in inflammatory disorders [23].
Several root, seed, aerial parts, fruit, and leaf extracts of A. tenuifolius showed strong
anti-microbial/antifungal against K. pneumoniae, P. aeruginosa, E. coli, S. aureus, Proteus mirabilis,
C. albicans, Aspergillus fumigatus, Vibrio cholerae, Salmonella typhi, and Candida glabrata, among other
pathogens [24,27,30,34,72,73]. Of note, there is no ethnomedical report of antimicrobial use of
A. tenuifolius.
The whole plant extract showed in vivo hypotensive and diuretic activity in normotensive rats [74].
The root extract of this species showed anti-oxidant activity (DPPH test, IC50 = 2.006 µg/mL) [25]
and asphorodin, a compound isolated from the whole plant extract, exhibit a potent inhibition of
lipoxygenase enzyme, (IC50 = 18.1 µM) [26], which may have an important role as an anti-inflammatory
agent. The biological properties of A. tenuifolius extracts prove their ethnomedical use mostly as
anti-inflammatory or diuretic [24–28,30,31,34].
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Table 3. In vitro and in vivo biological studies reported from the Asphodelus genus.
Species Part Extract Test/Assay Result Reference
A. aestivus L Aqueous, Ethanol
In vitro anti-fungal activity (A. niger)—Agar
well diffusion method (zone of inhibition
in cm−1)
Ethanol extract (0.25 and 0.5 mg/mL) showed higher activity than aqueous extract (0.25
and 0.5 mg/mL) and similar activity for concentrations of 1 mg/mL.
Both extracts were less active than Fluconazole (100 µ/mL)
[33]
In vitro antioxidant activity—β-carotene
bleaching effect, metal chelating, total
antioxidant activity, DPPH, ABTS,
superoxide radical scavenging activity,
hydroxyl radical scavenging activity, DMPD,
nitric oxide scavenging activity
Aqueous extract presented higher activity in metal chelating and radical scavenging assays
(DPPH, IC50 aqueous = 4.58 mg/mL and IC50 methanol = 9.54 mg/mL, superoxide, hydroxyl,
DMPD)
Ethanol extract presented higher activity in β-carotene bleaching effect and total
antioxidant activity
Aqueous and ethanolic extracts presented similar radical scavenging activity in ABTS and
NO assays. Both extracts presented significantly inferior results when compared to
reference substances
A. aestivus L Acetone, Methanol
In vitro antioxidant activity—β-carotene,
reducing power assay, DPPH, ABTS,
inhibition of linoleic acid peroxidation,
superoxide radical scavenging assays
Reducing power and total antioxidant activity were higher in acetone extract; free radical
and superoxide radical scavenging activity were higher in methanol extract (DPPH,
IC50 methanol = 0.16 mg/mL and IC50 acetone = 0.50 mg/mL)
Acetone extract presented higher activity in Reducing power and total antioxidant activity
(inhibition of linoleic acid peroxidation)
Methanol extract presented higher activity in superoxide radical scavenging and free
radical scavenging activity (β-carotene, ABTS and DPPH, IC50 methanol =0.16 mg/mL,
IC50acetone = 0.50 mg/mL)
[15]
A. aestivus L, R Dichloromethanen-Hexane
In vitro cytotoxic activity—MTT assay
against human lung cell cancer (A549) and
prostate cell cancer (PC3)
Root:
Dichloromethane: A549 (IC50 = 16 µg/mL); PC3 (IC50 = 19 µg/mL)
n-Hexane: PC3 (IC50 = 80 µg/mL)
Leaves:
Dichloromethane: A549 (IC50 = 90 µg/mL)
[69]
A. aestivus R Aqueous (decoction) In vivo anti-inflammatory—Ethanol inducedgastric ulcer model in rats Decoction gave significant protection against the lesions [32]
A. aestivus R
Aqueous (infusion and
decoction) Diethyl ether,
Ethyl acetate, Methanol
In vitro antioxidant activity—DPPH assay
Diethyl ether (IC50 = 22.46 µg/mL) have a higher scavenging activity than Ethyl acetate
(IC50 = 188.90 µg/mL), both have lower activity than reference substance, rutin
(7.77 µg/mL). Methanol and aqueous extract had no scavenging activity
[68]
In vitro cytotoxic & apoptotic
activity—MCF-7 breast cancer cells-trypan
blue exclusion assay, comet assay, Hoechst
33,258, propidium iodide double staining
Methanol and aqueous extracts exhibited strong cytotoxic activities. All extracts showed
significant DNA damaging and apoptotic activities.
A. aestivus SE Petroleum ether In vitro antimicrobial/fungal activity—brothmicrodilution method
Active against S. aureus (MIC = 512 µg/mL), Enteroococcus faecalis (MIC = 512 µg/mL),
K. pneumoniae (MIC = 512 µg/mL) and C. albicans (MIC = 512 µg/mL)
Not active against Bacillus cereus, Staphylococcus epidermidis, E. coli, P. aeruginosa,
S. typhimurium, Salmonella enterica, Candida krusei and Candida parapsilosis
[39]
A. aestivus WP n-Butanol, Ethanol In vitro anti-microbial/fungal activity—welland disk diffusion method
Active against S. aureus (MIC: 42 mg/mL), K. pneumoniae (MIC: 60 mg/mL), E. coli (MIC: 90
mg/mL), C. albicans (MIC: 90 mg/mL) [67]
A. aestivus WP Aqueous In vitro antioxidant activity—DPPH assay Inhibition % = 62.5 [75]
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Table 3. Cont.
Species Part Extract Test/Assay Result Reference
A. fistulosus
var. tenuifolius NI NI In vitro anti-microbial/fungal activity
Positive to S. aureus and no activity against E. coli, Proteus vulgaris, Salmonella sp.,
P. aeruginosa, C. albicans [76]
A. luteus * AP Aqueous In vitro anti-fungal activity—Agardilution method
Activity against T. violaceum (MIC = 18 µg/mL), M. canis (MIC = 25 µg/mL) and
T. mentagrophytes (MIC = 30 µg/mL) [18]
A. luteus * APR
Methanol,
Petroleum Ether
In vitro anti-microbial activity—agar
diffusion test; tetrazolium microplate assay
(MIC)
Against MRSA isolates
Methanol extract:
MIC (AP) = 1.25–2.5 mg/mL
MIC (R) = 0.65–1.25 mg/mL
Petroleum ether extract:
Root extract had higher activity than aerial part extract
[70]
A. luteus * R Methanol In vitro antioxidant activity—DPPH assay IC50 (methnol)= 0.54 mg/mL, IC50 (reference, BHT) = 0.017 mg/mL [61]
A. microcarpus AP Aqueous In vitro anti-fungal activity—Agar dilutionmethod
Weak activity against T. violaceum (MIC = 25 µg/mL) and no activity against M. canis and T.
mentagrophytes [18]
A. microcarpus APR Methanol
In vitro anti-microbial activity—agar
diffusion test; tetrazolium microplate assay
(MIC)
Against MRSA isolates
Methanol extract:
MIC (AP) = 1.25–5 mg/mL
MIC (R) = 1.25–2.5 mg/mL
[70]
A. microcarpus
FL
L
R
Aqueous, Ethanol,
Methanol
In vitro antimelanogenic
activity—tyrosinase inhibition (mushroom
tyrosinase assay and mouse melanoma cells
viability), kojic acid as positive control
Antimelanogenic activity
Ethanol extract (F) had the highest tyrosinase inhibition activity in mushroom assay and
melanoma cell assay
[47]
In vitro antioxidant activity—DPPH and
ABTS (reference—Trolox)
Antioxidant activity
DPPH (best activity)
Ethanol extract (F): IC50 = 28.4 µg/mL
Ethanol extract (L): IC50 = 55.9 µg/mL
Trolox: IC50 = 3.2 µg/mL
A. microcarpus L Ethanol
In vitro antimicrobial/fungal
activity—micro broth dilution method
Active against Bacillus clausii (MIC = 250 µg/mL), S. aureus (MIC = 250 µg/mL),
Staphylococcus haemolyticus (MIC = 250 µg/mL) and E. coli (MIC = 500 µg/mL).
No activity against Streptococcus spp. and yeasts
[49]In vitro antiviral activity (IFN-β
induction)—luciferase reporter gene assay
Antiviral activity
Active against EBOV in concentration of 0.1–3 µg/mL
In vitro cytotoxicity-Cell viability of A549
cells, positive control (camptothecin)
Cytotoxicity
IC50 (extract) > 100 µg/mL
IC50 (camptothecin) = 0.54 µg/mL
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Table 3. Cont.
Species Part Extract Test/Assay Result Reference
A. microcarpus L Methanol
In vitro antimicrobial/fungal—two-fold
serial dilution technique
Antimicrobial activity
Active against S. aureus (MIC = 78 µg/mL), Bacillus subtilis (MIC = 156 µg/mL), Salmonella
spp. (MIC = 313 µg/mL), E. coli (MIC = 125 µg/mL), Aspergillus flavus (MIC = 125 µg/mL),
C. albicans (MIC = 78 µg/mL)
[48]In vitro antiviral activity—CPE inhibition
assay against HSV-1 and HAV-10
Antiviral activity
Moderate activity against Hepatitis A virus (HAV-10) and no activity against Herpes
Simplex Virus (HSV-1)
In vitro cytotoxicity—viability assay against
human tumor cell lines of the lung (A-549),
colon (HCT-116), breast (MCF-7) and
prostate (PC3). Cisplatin as standard
Cytotoxicity
Highest activity against human lung carcinoma cells (A-549), IC50 = 29.3 µg/mL
A. microcarpus R Methnol In vitro antioxidant activity—DPPH assay IC50 (Methnol) = 0.30 mg/mL, IC50 (reference, BHT) = 0.017 mg/mL [61]
A. microcarpus R Methanol In vitro anti-microbial—Disk diffusion assay No activity against S. aureus, B. subtilis and E. coli [20]
A. microcarpus WP Aqueous, Ethanol
In vitro antioxidant activity—DPPH assay Ethanol extract (100 µg/mL) with moderate activity (inhibition percentage—60.3%) higherthan aqueous extract (100 µg/mL, inhibition percentage—49.5%)
[71]In vitro cytotoxic activity—Trypan blue
technique for Ehrlich Ascites Carcinoma
Cells (EACC)
Weak anti-cancer activity of both extracts
A. ramosus R Aqueous, Chloroform,Ethanol, Methanol
In vivo anti-inflammatory—Arachidonic
acid test (mouse ear oedema)
Carrageenan test (sub-plantar oedema)
Arachidonic acid test: Positive activity from chloroform and ethanol extracts
Carrageenan test: No activity was observed [23]
A. ramosus WP Aqueous, Methanol,Methanol 50%
In vitro antioxidant activity—DPPH assay at
35 ◦C and 65 ◦C Aqueous extract at 65
◦C had the highest inhibition percentage [77]
A. tenuifolius AP Butanol, Ethyl acetate,Methylene-chloride
In vitro anti-microbial/fungal activity—Disc
diffusion method
All extracts showed antimicrobial activity, the methylene-chloride as the most active
against S. aureus (MIC = 1.6 mg/mL), E. faecalis (MIC = 1.0 mg/mL), E. coli
(MIC = 1.8 mg/mL) and P. aeruginosa (MIC = 0.15 mg/mL)
All extracts showed antifungal activity against C. albicans, C. parapsilosis, C. glabrata,
C. krusei.
[30]
A. tenuifolius FR
Acetone, Aqueous,
Benzene, Chloroform,
Methanol,
Petroleum ether
In vitro anti-microbial/fungal
activity—Kirk-bauer disc diffusion method
Significant activity against S. aureus (acetone, MIC = 125 µg/mL); S. epidermidis (acetone,
MIC = 125 µg/mL; chloroform and methanol, MIC = 250 µg/mL); P. vulgaris (methanol,
MIC = 250 µg/mL; chloroform, MIC = 125 µg/mL), P. mirabilis (benzene, MIC = 125 µg/mL;
acetone and methanol, MIC = 250 µg/mL; chloroform, MIC = 500 µg/mL) E. coli (acetone,
chloroform and methanol, MIC = 125 µg/mL); K. pneumoniae (acetone and methanol, MIC
= 125 µg/mL; chloroform and benzene, MIC = 500 µg/mL); P. aeruginosa (acetone, MIC =
250 µg/mL; chloroform, MIC = 500 µg/mL); C. albicans (acetone, MIC = 125 µg/mL);
A. fumigatus (benzene and chloroform, MIC = 250 µg/mL; acetone, MIC = 500 µg/mL)
[27]
A. tenuifolius L Acetone, Methanol In vitro anti-microbial/fungalactivity—Agar disc diffusion method
Methanol extract positive against S. aureus, B. cereus, Citrobacter freundii, Candida tropicalis
and acetone extract was positive against K. pneumoniae, C. tropicalis and Cryptococcus luteolus [24]
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Table 3. Cont.
Species Part Extract Test/Assay Result Reference
A. tenuifolius R Methanol
In vitro antioxidant activity—DPPH, ABTS+,
NO, OH, O2−, ONOO− assays, Oxidative
DNA damage
Positive activity, DPPH (IC50 = 2.006 µg/mL), ABTS·+ (IC50 = 156.94 µg/mL), NO (nd),
OH (IC50 = 50.13 µg/mL), O2− (IC50 = 425.92 µg/mL) and ONOO- (IC50 = 3.390 µg/mL),
oxidative DNA damage: 1.85 µg/mL of extract prevented DNA damage.
[25]
A. tenuifolius R
Benzene, Chloroform,
Ethyl acetate, Methanol,
Petroleum ether
In vitro anti-microbial/fungal activity—Disc
diffusion method
All extracts were active against B. subtilis, P. vulgaris, P. aeruginosa, Trichophyton rubrum,
E. coli, K. pneumoniae, Shigella sonnei, S. aureus, C. albicans, A. niger and A. flavus [72]
A. tenuifolius SE
Aqueous, Ethanol,
Methanol,
Petroleum ether
In vitro anti-microbial/fungal
activity—modified Kirby Bauer disc
diffusion method
Petroleum ether: no antibacterial activity
Ethanol: activity against P. aeruginosa, Vibrio cholerae and S. aureus (MIC = 16 µg/mL);
P. mirabilis, S. typhi, Shigella flexneri and Serratia marcescens (MIC = 32 µg/mL).
Methanol: activity against S. aureus (MIC = 16 µg/mL); V. cholerae, P. aeruginosa, S. typhi,
S. flexneri and S. marcescens (MIC = 16 µg/mL)
Aqueous: activity against V. cholerae, S. aureus, S. typhi and S. flexneri (MIC = 32 µg/mL);
P. aeruginosa and P. mirabilis (MIC = 16 µg/mL).
No antifungal activity against C. albicans and A. niger
[34]
A. tenuifolius WP Methanol
In vitro antimicrobial/fungal activity—disk
diffusion method
In vitro anti-parasitic activity—trophozoites
growth inhibition assay
Good activity against E. coli and moderate activity against S. aureus, S. typhi, K. pneumoniae,
P. aeruginosa, C. albicans and A. niger
Active against Giardia lamblia (IC50 = 219.82 µg/mL) and Entamoeba histolytica
(IC50 = 344.62 µg/mL)
[73]
A. tenuifolius WP Aqueous
In vivo hypotensive activity—blood
pressure (BP) measure after parenteral
administration of aqueous extracts in rats.
Acetylcholine and verapamil as positive
controls in co administration with atropine
Hypotensive activity
The extract decreased blood pressure in normotensive rats (35.2% decrease with
30 mg/Kg), similar to Verapamil. The response was independent from atropine effect
[74]
In vivo diuretic activity—measure of rat
urine output and urinary electrolytes. After
6 hr administration. Saline solution and
furosemide as controls
Diuretic activity
Significant increase in urinary volume and electrolytes excretion with 300 and 500 mg/Kg
AP: Aerial Part; FL: Flower; FR: Fruit; L: Leaf; R: Root; SE: Seed; WP: Whole plant; NI: Not indicated; * Asphodelus luteus L.—synonym of Asphodeline lutea was formerly included in the family
Asphodelaceae. ABTS+: 2,2′-azinobis-(3-ethylbenzothiazole-6-sulphonate) radical cation, DMPD: N,N-dimethyl-p-phenylenediamine dihydrochloride, DPPH: 2,2-diphenyl-1-picrylhydrazyl
radical, NO: nitric oxide radical, O2.–: superoxide anion radical , ·OH: hydroxyl radical, ONOO-: Peroxynitrite radicals, EBOV: Ebola virus.
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Table 4. In vitro and in vivo biological studies reported from pure compounds isolated from Asphodelus genus.
Species Pure Compounds Test/Assay Result Reference
A. microcarpus
Asphodelin A 4′-O-β-D-glucoside (1), Asphodelin A (2) In vitro antimicrobial/fungalactivity—micro dilution assay
S. aureus (MIC1 = 128 µg/mL, MIC2 = 16 µg/mL), E. coli (MIC1 =
128 µg/mL, MIC2 = 4 µg/mL), P. aeruginosa (MIC1 = 256 µg/mL,
MIC2 = 8 µg/mL), C. albicans (MIC1 = 512 µg/mL, MIC2 = 64
µg/mL) and B. cinerea (MIC1 = 1024 µg/mL, MIC2 = 128 µg/mL
[19]
3-methyl anthraline, chrysophanol, and aloe-emodine Psoriasis Positive (patent) [78,79]
1,6-dimethoxy-3-methyl-2-naphthoic acid (1), asphodelin (2),
chrysophanol (3), 8 methoxychrysophanol (4), emodin (5),
2-acetyl-1,8-dimethoxy-3-methylnaphthalene (6),
10-(chrysophanol-7′-yl)-10-hydroxychrysophanol-9-anthrone
(7), aloesaponol-III-8-methyl ether (8), ramosin (9), aestivin (10)
In vitro anti-parasitic activity
Compounds 3 and 4 showed moderate to weak against a culture
of L. donovani promastigotes (IC50 = 14.3 and 35.1 µg/mL,
respectively)
[21]
In vitro cytotoxic activity-Human acute
leukemia HL60 cells/human chronic
leukemia 562 cells
Compounds 7 and 9 exhibited a potent cytotoxic activity against
leukemia LH60 and K562 cell lines
In vitro antimalarial
activity—chloroquine sensitive &
resistant strains of Plasmodium
falciparum (plasmodial LDH activity)
Compound 10 showed potent antimalarial activities against both
chloroquine-sensitive and resistant strains of P. falciparum (IC50 =
0.8–0.7 µg/mL) without showing any cytotoxicity to
mammalian cells
In vitro anti-microbial/fungal activity
Compound 4 exhibited moderate antifungal activity against
Cryptococcus neoformans (IC50 = 15.0 µg/mL), compounds 5, 7
and 10 showed good to potent activity against methicillin
resistant S. aureus (MRSA) (IC50 = 6.6, 9.4 µg/mL and 1.4 µg/mL
respectively). Compounds 5, 8 and 9 displayed good activity
against S. aureus (IC50 = 3.2, 7.3 and 8.5 µg/mL, respectively)
Methyl-1,4,5-trihydroxy-7-methyl-9,10-dioxo-9,10-
dihydroanthracene-2-carboxylate (1), (1R)
3,10-dimethoxy-5-methyl-1H-1,4 epoxybenzo[h]isochromene
(2), 3,4-dihydroxy-methyl benzoate (3), 3,4-dihydroxybenzoic
acid (4), 6 methoxychrysophanol (6)
In vitro anti-parasitic activity Compound 3 showed activity against a culture of L. donovanipromastigotes (IC50 = 33.2 µg/mL)
[54]
In vitro anti-microbial/activity
Compound 1 showed a potent activity against methicillin
resistant S. aureus (MRSA) and S. aureus (IC50: 1.5 and 1.2 µg/mL,
Respectively)
5 Compounds, Asphodosides A–E In vitro anti-microbial activity
Compounds 2–4 showed activity against methicillin resistant
S. aureus (MRSA) (IC50: 1.62, 7.0 and 9.0 µg/mL, respectively).
activity against S. aureus (non-MRSA), IC50 = 1.0, 3.4 and
2.2 µg/mL, respectively
[51]
A. tenuifolius Asphorodin In vitro anti-inflammatory-inhibition oflipoxigenase enzyme
Potent inhibitory activity (IC50 = 18.1 µM), Reference: baicalein
(22.6 µM) [26]
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3. Materials and Methods
Ethnobotanical data was collected by our team in Portugal and relevant literature was reviewed
until December 2017, by probing scientific databases (PubMed, Scopus, Google Scholar, b-on,
Web of knowledge) and other web sources such as records from WCSP, IUCN, APG and the
Missouri Botanical Garden database. Various keywords were used during the bibliographic research
including: ASPHODELUS SPECIES; TRADITIONAL USES; ETHNOMEDICINAL EVIDENCE;
BIOLOGICAL ACTIVITIES; ISOLATED MOLECULES; PHYTOCHEMISTRY. Information was
gathered and summarized in table form where appropriate.
4. Conclusions
In conclusion, among the 18 species of the genus Asphodelus, only 30 percent of the species namely
A. aestivus, A. fistulosus, A. microcarpus, A. ramosus, and A. tenuifolius have been documented for their
traditional uses. In phytochemical studies 50 percent of the species (A. acaulis, A. aestivus, A. albus,
A. cerasifer, A. fistulosus, A. macrocarpus, A. microcarpus, A. ramosus, A. tenuifolius) have been evaluated
for their constituents however there is no documented data related to traditional uses of A. acaulis,
A. albus and A. cerasiferus.
All the species with ethnomedical documented data were submitted to biological activity
tests, showing a total or partial correlation with their traditional use as anti-microbial, anti-fungal,
anti-parasitic, cytotoxic, anti-inflammatory, or antioxidant agents.
Root tubers plant part were mainly reported to have anthraquinone derivatives, triterpenoids,
and naphthalene derivatives, while aerial parts mostly exhibited the presence of flavonoids, phenolic
acids, and few anthraquinones.
Considering the previous phytochemical studies, 1,8 dihydroxyanthracene derivatives (e.g.,
aloe-emodin and chrysophanol) were the most common reported anthraquinones of A. aestivus,
A. luteus and A. microcarpus extracts which could be responsible for the reported antimicrobial/fungal
activities [78,80]. Aloe-emodin as a potent cytotoxic compound might be related to the reported
anti-tumoral activity of A. aestivus [68,78].
Flavonoids namely luteolin and apigenin derivatives were frequently reported from the
aerial parts of all studied Aphodelus species, which according to their known antioxidant and
anti-inflammatory properties [81,82], could be correlated to their traditional uses in inflammatory
diseases in agreement with the reported biological studies. Phenolic acids, namely caffeic acid and
chlorogenic acid reported from aerial parts and root tubers might be responsible for the general
antioxidant activity presented in the biological studies.
Phytosterols (e.g., fucosterol, β-sitosterol, and stigmasterol) and β-amyrin were the most
common found triterpenoids from roots and seeds. According to the literature, β-amyrin possess
antibacterial/antifungal properties [83] which complement the reported biological activities of
A. tenuifolius.
The present study allowed the importance and potential of the genus Asphodelus as a source
of new compounds to be ascertained, with biological activity and new herbal products based on
Asphodelus genus used in traditional medicine being ascertained, as well as its quality, mode of action,
and safety of use. It should be pointed out that, to the best of our knowledge, the latter aspect (the
safety of Asphodelus species) has not yet been the object of in-depth studies.
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